Cargando…
Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding RNAs
Breast cancer is the most common malignant tumors in females. Although the conventional treatment has demonstrated a certain effect, some limitations still exist. The Rho guanosine triphosphatase (GTPase) Cdc42 (Cell division control protein 42 homolog) is often upregulated by some cell surface rece...
Autores principales: | Zhang, Yu, Li, Jun, Lai, Xing-Ning, Jiao, Xue-Qiao, Xiong, Jun-Ping, Xiong, Li-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406589/ https://www.ncbi.nlm.nih.gov/pubmed/30754684 http://dx.doi.org/10.3390/cells8020146 |
Ejemplares similares
-
Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases
por: Huang, Qi-Yuan, et al.
Publicado: (2019) -
Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin Secretion Via Wnt/β-Catenin Signaling
por: Xiao, Xing-Hua, et al.
Publicado: (2019) -
The small GTPase CDC42 regulates actin dynamics during porcine oocyte maturation
por: ZHANG, Yu, et al.
Publicado: (2017) -
Phenotypic characterisation of breast cancer: the role of CDC42
por: Chrysanthou, Eleni, et al.
Publicado: (2017) -
The Borg family of Cdc42 effector proteins Cdc42EP1–5
por: Farrugia, Aaron J., et al.
Publicado: (2016)